Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program

KD Tew, A Monks, L Barone, D Rosser, G Akerman, JA Montali, JB Wheatley and DE Schmidt

Department of Pharmacology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA. kd.tew@fccc.edu

The steady state expression of glutathione S-transferases (GSTs) at both the protein and mRNA level is reported for the 60 tumor cell lines that are used for the National Cancer Institute Drug Screening Program. Individual GST isozymes were separated, identified, and quantified (with reverse-phase calibration curves) through a novel high performance liquid chromatographic procedure. GSTP1 was the predominant isozyme and was found at quantifiable levels in all but two of the cell lines. This isozyme ranged from 0.03% to 2.7% of the total cytosolic protein. For the mu family, 90% of the lines had GSTM2, 68% had GSTM3, but only 28% were positive for the M1 phenotype. The M1 proportion is lower than would be expected from the standard M1 null phenotype for human populations. Isozymes of the alpha family were detected only at very low levels in 35% of the lines. Significant quantitative correlations among enzyme activity, total enzyme protein, and mRNA were shown for GSTP1. However, such relationships were not apparent for the mu or alpha families. Levels of glutathione (GSH), and the transcript levels of other enzymes involved in GSH homeostasis were determined. gamma-Glutamyl cysteine synthetase (gamma-GCS) was present in all cell lines, but did not correlate with levels of intracellular GSH. Glyoxalase-I and gamma-glutamyl transpeptidase, both involved in GSH salvage, were found in 100% and 70% of the cell lines, respectively. Using a pattern-matching computer program, COMPARE, we compared and correlated the arrays of mRNA and protein levels with the pattern of chemosensitivity or chemoresistance of the 60 cell lines with 175 agents constituting a standard agent database. This database is composed of compounds to which a putative mechanism of action has been assigned. Although Pearson correlation coefficients relating the target and drug patterns were generally modest, when the patterns for the enzyme protein and mRNA levels for GST pi were correlated to drug sensitivity patterns, the list of 30 agents most closely matching (for which P < 0.05) was enriched with alkylating agents. gamma-GCS also showed an enrichment of alkylating agents in the COMPARE correlations, indicating that high levels of gamma-GCS may be an important determinant of resistance. In contrast, none of the other enzymes or GSH had patterns of expression that resulted in an obvious correlation to the sensitivity or resistance of alkylating agents.

Volume 50, Issue 1, pp. 149-159, 07/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				M. Pasello, F. Michelacci, I. Scionti, C. M. Hattinger, M. Zuntini, A. M. Caccuri, K. Scotlandi, P. Picci, and M. Serra Overcoming Glutathione S-Transferase P1-Related Cisplatin Resistance in Osteosarcoma Cancer Res., August 15, 2008; 68(16): 6661 - 6668. [Abstract] [Full Text] [PDF]

				N. N. Raveendran, K. Silver, L. C. Freeman, D. Narvaez, K. Weng, S. Ganta, and J. D. Lillich Drug-Induced Alterations to Gene and Protein Expression in Intestinal Epithelial Cell 6 Cells Suggest a Role for Calpains in the Gastrointestinal Toxicity of Nonsteroidal Anti-Inflammatory Agents J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 389 - 399. [Abstract] [Full Text] [PDF]

				C. Duret, S. Gerbal-Chaloin, J. Ramos, J.-M. Fabre, E. Jacquet, F. Navarro, P. Blanc, A. Sa-Cunha, P. Maurel, and M. Daujat-Chavanieu Isolation, Characterization, and Differentiation to Hepatocyte-Like Cells of Nonparenchymal Epithelial Cells from Adult Human Liver Stem Cells, July 1, 2007; 25(7): 1779 - 1790. [Abstract] [Full Text] [PDF]

				M. J. Del Prete, R. Vernal, H. Dolznig, E. W. Mullner, and J. A. Garcia-Sanz Isolation of polysome-bound mRNA from solid tissues amenable for RT-PCR and profiling experiments RNA, March 1, 2007; 13(3): 414 - 421. [Abstract] [Full Text] [PDF]

				S. Cauchi, W. Han, S. V. Kumar, and S. D. Spivack Haplotype-environment interactions that regulate the human glutathione s-transferase p1 promoter. Cancer Res., June 15, 2006; 66(12): 6439 - 6448. [Abstract] [Full Text] [PDF]

				Y. Huang, Z. Dai, C. Barbacioru, and W. Sadee Cystine-Glutamate Transporter SLC7A11 in Cancer Chemosensitivity and Chemoresistance Cancer Res., August 15, 2005; 65(16): 7446 - 7454. [Abstract] [Full Text] [PDF]

				G. Ricci, F. De Maria, G. Antonini, P. Turella, A. Bullo, L. Stella, G. Filomeni, G. Federici, and A. M. Caccuri 7-Nitro-2,1,3-benzoxadiazole Derivatives, a New Class of Suicide Inhibitors for Glutathione S-Transferases: MECHANISM OF ACTION OF POTENTIAL ANTICANCER DRUGS J. Biol. Chem., July 15, 2005; 280(28): 26397 - 26405. [Abstract] [Full Text] [PDF]

				J.-M. Lee, M.-T. Wu, Y.-C. Lee, S.-Y. Yang, J.-S. Chen, H.-H. Hsu, P.-M. Huang, S.-W. Kuo, C.-J. Lee, and C.-J. Chen Association of GSTP1 Polymorphism and Survival for Esophageal Cancer Clin. Cancer Res., July 1, 2005; 11(13): 4749 - 4753. [Abstract] [Full Text] [PDF]

				P. Turella, C. Cerella, G. Filomeni, A. Bullo, F. De Maria, L. Ghibelli, M. R. Ciriolo, M. Cianfriglia, M. Mattei, G. Federici, et al. Proapoptotic Activity of New Glutathione S-Transferase Inhibitors Cancer Res., May 1, 2005; 65(9): 3751 - 3761. [Abstract] [Full Text] [PDF]

				S. Gunnarsdottir and A. A. Elfarra CYTOTOXICITY OF THE NOVEL GLUTATHIONE-ACTIVATED THIOPURINE PRODRUGS CIS-AVTP [CIS-6-(2-ACETYLVINYLTHIO)PURINE] AND TRANS-AVTG [TRANS-6-(2-ACETYLVINYLTHIO)GUANINE] RESULTS FROM THE NATIONAL CANCER INSTITUTE'S ANTICANCER DRUG SCREEN Drug Metab. Dispos., March 1, 2004; 32(3): 321 - 327. [Abstract] [Full Text] [PDF]

				A. M. Wheelock, L. Zhang, M.-U. Tran, D. Morin, S. Penn, A. R. Buckpitt, and C. G. Plopper Isolation of rodent airway epithelial cell proteins facilitates in vivo proteomics studies of lung toxicity Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L399 - L410. [Abstract] [Full Text] [PDF]

				G. Chen, T. G. Gharib, C.-C. Huang, J. M. G. Taylor, D. E. Misek, S. L. R. Kardia, T. J. Giordano, M. D. Iannettoni, M. B. Orringer, S. M. Hanash, et al. Discordant Protein and mRNA Expression in Lung Adenocarcinomas Mol. Cell. Proteomics, April 1, 2002; 1(4): 304 - 313. [Abstract] [Full Text] [PDF]

				A. C. Walsh, J. A. Feulner, and A. Reilly Evidence for Functionally Significant Polymorphism of Human Glutamate Cysteine Ligase Catalytic Subunit: Association with Glutathione Levels and Drug Resistance in the National Cancer Institute Tumor Cell Line Panel Toxicol. Sci., June 1, 2001; 61(2): 218 - 223. [Abstract] [Full Text] [PDF]

				L. J. Yu, J. Matias, D. A. Scudiero, K. M. Hite, A. Monks, E. A. Sausville, and D. J. Waxman P450 Enzyme Expression Patterns in the NCI Human Tumor Cell Line Panel Drug Metab. Dispos., March 1, 2001; 29(3): 304 - 312. [Abstract] [Full Text]

				E Maellaro, S Dominici, B Del Bello, M. Valentini, L Pieri, P Perego, R Supino, F Zunino, E Lorenzini, A Paolicchi, et al. Membrane gamma-glutamyl transpeptidase activity of melanoma cells: effects on cellular H(2)O(2) production, cell surface protein thiol oxidation and NF-kappa B activation status J. Cell Sci., January 8, 2000; 113(15): 2671 - 2678. [Abstract] [PDF]

				M. H. Hanigan, B. C. Gallagher, D. M. Townsend, and V. Gabarra {gamma}-glutamyl transpeptidase accelerates tumor growth and increases the resistance of tumors to cisplatin in vivo Carcinogenesis, April 1, 1999; 20(4): 553 - 559. [Abstract] [Full Text] [PDF]

				B. D. Bello, A. Paolicchi, M. Comporti, A. Pompella, and E. Maellaro Hydrogen peroxide produced during {gamma}-glutamyl transpeptidase activity is involved in prevention of apoptosis and maintainance of proliferation in U937 cells FASEB J, January 1, 1999; 13(1): 69 - 79. [Abstract] [Full Text]

				Z.-P. Chen, A. Malapetsa, A. McQuillan, D. Marcantonio, V. Bello, G. Mohr, J. Remack, T. P. Brent, and L. C. Panasci Evidence for Nucleotide Excision Repair as a Modifying Factor of O6-Methylguanine-DNA Methyltransferase-Mediated Innate Chloroethylnitrosourea Resistance in Human Tumor Cell Lines Mol. Pharmacol., November 1, 1997; 52(5): 815 - 820. [Abstract] [Full Text]

				Y.-H. He, Y. Xu, M. Kobune, M. Wu, M. R. Kelley, and W. J. Martin II Escherichia coli FPG and human OGG1 reduce DNA damage and cytotoxicity by BCNU in human lung cells Am J Physiol Lung Cell Mol Physiol, January 1, 2002; 282(1): L50 - L55. [Abstract] [Full Text] [PDF]